Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Hey Guys Me Again

<< Previous

Bullboard Posts

Next >>

Comment by MaxJaxStaxon Jan 25, 2021 2:21pm

152 Views

Post# 32377312

RE:RE:RE:RE:Hey Guys Me Again

I appreciate your caring attitude towards a total stranger.... it is so rare you find such love and beauty in this world. Losingmyshirt you sir/Ms. are truely a kind, caring, loving person and i appreciate you.

Be safe out there pal, its a crazy world we live in.... As my good friend Robert says "The stock market is less volatile then most my romantic relationships!" hahaha that guys kills me.... he is married and still likes to party.

Remember friends... big news coming... take it or leave it.... MAXJAXSTAX has spoken.

PS. STUPIDIER ISNT A WORD - TABLES TURNED - MIC DROP

Peace, LOVE, and Harmony